ESC 365 - Diagnosis and monitoring of enzyme replacement therapy: from ECG to standard echo.

EACVI Premium Access

Diagnosis and monitoring of enzyme replacement therapy: from ECG to standard echo.

Session: Multi-modality imaging approach to Fabry cardiomyopathy

Topic: Imaging of Myocardial Disease

Speaker: Professor D. Mohty (Riyadh, SA)

Event: EuroEcho 2019

Congress Presentation

About the speaker

Professor Dania Mohty

King Faisal Specialist Hospital & Research Centre, Riyadh (Saudi Arabia)

4 presentations

0 follower

3 more presentations in this session

The role of speckle tracking echocardiography for an early diagnosis.

Speaker: Doctor M. Lembo (Naples, IT)

Is cardiac MRI absolutely needed for diagnosing Fabry cardiomyopathy?

Speaker: Professor B. Gerber (Brussels, BE)

Any role for nuclear cardiology techniques?

Speaker: Doctor W. Acampa (Napoli, IT)

Access the full session

Multi-modality imaging approach to Fabry cardiomyopathy

Speakers: Professor D. Mohty, Doctor M. Lembo, Professor B. Gerber, Doctor W. Acampa

About the event

EuroEcho 2019

4 December - 7 December 2019

Sessions Presentations

Congress

Related content

EACVI Premium Access

What is severe tricuspid regurgitation and how to grade it.

10 December 2021

EACVI Premium Access

How and why to assess the functional anatomy and etiology of TR.

10 December 2021

Open Access

ICD Therapy in 2021: Saving lives while reducing shocks.

29 August 2021

ESC 365 is supported by